HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Field assessment of the direct nitrate reductase assay for rapid detection of multidrug-resistant tuberculosis in Honduras.

AbstractSETTING:
The national TB reference laboratory and four health care units connected to the national laboratory network in Honduras, Central America.
OBJECTIVE:
To evaluate the performance of the direct nitrate reductase assay (NRA) for rapid, low-cost detection of multidrug-resistant tuberculosis (MDR-TB) in a resource-limited setting.
DESIGN:
Consecutive smear-positive samples (n = 185) were prospectively analysed with NRA and compared to the proportion method on Löwenstein Jensen medium (PM-LJ) to detect resistance to isoniazid (INH) and rifampicin (RMP).
RESULTS:
The NRA sensitivity, specificity, positive and negative predictive values for INH and RMP were respectively 100%, 99%, 91%, 100% and 80%, 100%, 100%, 99%. Good agreement was observed between NRA and PM-LJ (κ > 0.8).
CONCLUSION:
The direct NRA is a reliable alternative for rapid and low-cost identification of MDR-TB cases in resource-limited settings.
AuthorsS Rosales, N Almendarez, H Membreño, S E Hoffner, L Pineda-Garcia
JournalThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease (Int J Tuberc Lung Dis) Vol. 15 Issue 9 Pg. 1206-10, i (Sep 2011) ISSN: 1815-7920 [Electronic] France
PMID21943847 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antitubercular Agents
  • Nitrate Reductase
  • Isoniazid
  • Rifampin
Topics
  • Antitubercular Agents (pharmacology)
  • Honduras
  • Humans
  • Isoniazid (pharmacology)
  • Microbial Sensitivity Tests
  • Nitrate Reductase (metabolism)
  • Predictive Value of Tests
  • Prospective Studies
  • Rifampin (pharmacology)
  • Sensitivity and Specificity
  • Sputum (microbiology)
  • Tuberculosis, Multidrug-Resistant (diagnosis, drug therapy, enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: